ERYTHROMYCIN ETHYLSUCCINATE is a Oral Suspension in the Human Prescription Drug category. It is labeled and distributed by Wilshire Pharmaceuticals. The primary component is Erythromycin Ethylsuccinate.
| Product ID | 52536-130_240e9111-2531-403a-bbd3-161d87185b1e |
| NDC | 52536-130 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ERYTHROMYCIN ETHYLSUCCINATE |
| Generic Name | Erythromycin Ethylsuccinate |
| Dosage Form | Suspension |
| Route of Administration | ORAL |
| Marketing Start Date | 2019-03-25 |
| Marketing Category | NDA / NDA |
| Application Number | NDA050207 |
| Labeler Name | Wilshire Pharmaceuticals |
| Substance Name | ERYTHROMYCIN ETHYLSUCCINATE |
| Active Ingredient Strength | 400 mg/5mL |
| Pharm Classes | Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2019-03-25 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA205136 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-04-15 |
| Marketing End Date | 2019-04-12 |
| Marketing Category | ANDA |
| Application Number | ANDA205136 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-04-15 |
| Marketing End Date | 2019-04-12 |
| Marketing Category | NDA |
| Application Number | NDA050207 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2019-03-25 |
| Ingredient | Strength |
|---|---|
| ERYTHROMYCIN ETHYLSUCCINATE | 400 mg/5mL |
| SPL SET ID: | 86d6353c-2b58-4219-b31d-fb5b97789094 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |